Clinical Trials Browser

Phase 2/3 × Prostatic Neoplasms × Methylphenidate × Clear all

NCT03772834 2025-10-10

Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

Phase 2/3 Active not recruiting

Prostatic Neoplasms